DrugPatentWatch Database Preview
SYMLIN Drug Patent Profile
Email this page to a colleague
Which patents cover Symlin, and what generic alternatives are available?
Symlin is a drug marketed by Astrazeneca Ab and is included in one NDA.
The generic ingredient in SYMLIN is pramlintide acetate. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pramlintide acetate profile page.
Summary for SYMLIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 11 |
| Clinical Trials: | 20 |
| Patent Applications: | 3,891 |
| Drug Prices: | Drug price information for SYMLIN |
| DailyMed Link: | SYMLIN at DailyMed |
Recent Clinical Trials for SYMLIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Institute on Aging (NIA) | Early Phase 1 |
| Boston University | Early Phase 1 |
| H. Lee Moffitt Cancer Center and Research Institute | Early Phase 1 |
Pharmacology for SYMLIN
| Drug Class | Amylin Analog |
| Mechanism of Action | Amylin Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for SYMLIN
US Patents and Regulatory Information for SYMLIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca Ab | SYMLIN | pramlintide acetate | INJECTABLE;SUBCUTANEOUS | 021332-002 | Sep 25, 2007 | RX | Yes | No | ⤷ Try it Free | ⤷ Try it Free | ⤷ Try it Free | ||||
| Astrazeneca Ab | SYMLIN | pramlintide acetate | INJECTABLE;SUBCUTANEOUS | 021332-003 | Sep 25, 2007 | RX | Yes | Yes | ⤷ Try it Free | ⤷ Try it Free | ⤷ Try it Free | ||||
| Astrazeneca Ab | SYMLIN | pramlintide acetate | INJECTABLE;SUBCUTANEOUS | 021332-001 | Mar 16, 2005 | DISCN | No | No | ⤷ Try it Free | ⤷ Try it Free | ⤷ Try it Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SYMLIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Astrazeneca Ab | SYMLIN | pramlintide acetate | INJECTABLE;SUBCUTANEOUS | 021332-002 | Sep 25, 2007 | ⤷ Try it Free | ⤷ Try it Free |
| Astrazeneca Ab | SYMLIN | pramlintide acetate | INJECTABLE;SUBCUTANEOUS | 021332-003 | Sep 25, 2007 | ⤷ Try it Free | ⤷ Try it Free |
| Astrazeneca Ab | SYMLIN | pramlintide acetate | INJECTABLE;SUBCUTANEOUS | 021332-001 | Mar 16, 2005 | ⤷ Try it Free | ⤷ Try it Free |
| Astrazeneca Ab | SYMLIN | pramlintide acetate | INJECTABLE;SUBCUTANEOUS | 021332-002 | Sep 25, 2007 | ⤷ Try it Free | ⤷ Try it Free |
| Astrazeneca Ab | SYMLIN | pramlintide acetate | INJECTABLE;SUBCUTANEOUS | 021332-001 | Mar 16, 2005 | ⤷ Try it Free | ⤷ Try it Free |
| Astrazeneca Ab | SYMLIN | pramlintide acetate | INJECTABLE;SUBCUTANEOUS | 021332-001 | Mar 16, 2005 | ⤷ Try it Free | ⤷ Try it Free |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for SYMLIN
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Austria | 172540 | ⤷ Try it Free |
| Hungary | 9302061 | ⤷ Try it Free |
| Finland | 883936 | ⤷ Try it Free |
| Norway | 883828 | ⤷ Try it Free |
| Greece | 3026640 | ⤷ Try it Free |
| World Intellectual Property Organization (WIPO) | 03101395 | ⤷ Try it Free |
| >Country | >Patent Number | >Estimated Expiration |
